Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,909,959,895
+$4,301,398,463 QoQ
Shares Held
16,320,446
+257.0% QoQ
Ownership
3.02%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#5
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. AMGN ranks #1 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
This page
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,033,480 | $923,849,108 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,909,959,895 | 16,320,446 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,608,561,432 | 4,571,725 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,567,310,835 | 4,788,460 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,260,668,383 | 4,467,287 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,169,961,364 | 4,190,256 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,199,623,576 | 3,850,501 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,013,172,308 | 3,887,248 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,165,469,968 | 3,617,113 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,022,886,927 | 3,273,762 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $880,398,859 | 3,096,507 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,003,704,181 | 3,484,842 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $902,055,034 | 3,356,359 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $643,196,150 | 2,897,019 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $766,495,441 | 3,170,612 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $730,059,085 | 2,779,695 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $591,374,534 | 2,623,667 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $662,448,961 | 2,722,766 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $674,857,705 | 2,790,744 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $550,247,142 | 2,445,869 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $406,701,836 | 1,912,541 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $419,257,306 | 1,720,030 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $541,519,034 | 2,176,436 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $498,989,851 | 2,170,276 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $808,704,580 | 3,181,872 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $547,218,777 | 2,320,100 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $364,986,162 | 1,800,356 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||